APOE and hyperlipidemia: We showed that the treatment of chow-diet-fed male APOE knockout mice with a standard oral dose of 10 mg/kg/day LXR agonist T0901317 was associated with hepatic fat accumulation, exacerbated hyperlipidemia, and monocytosis and stimulated early atherosclerotic lesion development.